Bright prospect expected for drug makers in third quarter
Published: 2012-10-05 06:58:00
Updated: 2012-10-05 06:58:00
Optimism is growing over the third quarter outlook for Korea’ leading pharmaceutical firms as they are pushing up with co-marketing strategies with multinational firms, according to a report by Shinhan Finance & Investment Securities.
The report showed that the combined revenue of the large ei...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
